尿动力学检查鉴别多系统萎缩与帕金森病
本研究回顾性分析2011年1月至2018年8月接受尿动力学检查的219例多系统萎缩(MSA)或帕金森病(PD)患者,其中MSA 107例、PD 112例。MSA患者最大尿流率更低、残余尿量更大、膀胱顺应性降低及收缩力受损更明显,而PD患者逼尿肌过度活动及相关漏尿更突出。压力-流率测定的残余尿量鉴别敏感度与特异度最高(74.8%和75.9%)。
要点
- MSA患者尿动力学特征为低尿流率、大残余尿、低顺应性和收缩力受损。
- PD患者更常见逼尿肌过度活动及相关漏尿。
- 压力-流率测定的残余尿量鉴别MSA与PD的敏感度和特异度最高。
核心结论
- 尿动力学检查有助于鉴别MSA与PD,其中压力-流率测定的残余尿量诊断效能最佳。
研究设计与样本
- 回顾性队列研究,纳入2011年1月至2018年8月在本中心经运动障碍专家诊断为很可能MSA或PD并接受尿动力学检查的患者219例(MSA 107例,PD 112例)。
主要发现
- MSA患者病程更短且更早转诊进行泌尿系统评估(p < 0.001)。
- PD患者逼尿肌过度活动及相关漏尿更突出(p < 0.001)。
- MSA患者最大尿流率更低(4.0 ± 5.8 vs 9.1 ± 8.3 mL/s,p < 0.001),残余尿量更大(290.8 ± 196.7 vs 134.0 ± 188.1 mL,p < 0.001),膀胱顺应性降低(44.9% vs 10.7%,p < 0.001),收缩力受损(24.9 ± 33.8 vs 65.7 ± 51.1,p < 0.001)。
关键数值与推荐
- 压力-流率测定的残余尿量鉴别MSA与PD的敏感度为74.8%、特异度为75.9%。
- 最大尿流率时逼尿肌压力敏感度72.6%、特异度70.5%。
- 膀胱收缩力指数及尿流率测定残余尿量的敏感度均为71.0%、特异度均为70.5%。
临床怎么用
- 对临床表现重叠的MSA与PD患者,可考虑尿动力学检查辅助鉴别,尤其关注压力-流率测定的残余尿量。
局限性
- 本研究为回顾性设计,证据等级为Class III。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the differences in urodynamic findings between multiple system atrophy (MSA) and Parkinson disease (PD) and to identify the differential diagnostic ability of urodynamic study. METHODS: We reviewed patients with MSA or PD who underwent urodynamic studies between January 2011 and August 2018. Patients with probable MSA and PD determined by movement disorder specialists at our center were included. Patients with alleged MSA or PD from outside hospitals, atypical or secondary parkinsonism, and any history of pelvic operation or radiation therapy were excluded. RESULTS: A total of 219 patients, 107 with MSA (male:female 50:57) and 112 with PD (male:female 57:55), were included. Patients with MSA had shorter disease duration and were referred for urologic evaluation earlier (p < 0.001). Detrusor overactivity and associated urine leakage were prominent in PD (p < 0.001). Patients with MSA showed lower maximal flow rate (4.0 ± 5.8 vs 9.1 ± 8.3 mL/s, p < 0.001) and larger postvoid residual (290.8 ± 196.7 vs 134.0 ± 188.1 mL, p < 0.001) with decreased compliance (44.9% vs 10.7%, p < 0.001) and impaired contractility (24.9 ± 33.8 vs 65.7 ± 51.1, p < 0.001). Postvoid residual from a pressure-flow study had the highest sensitivity and specificity (74.8% and 75.9%), followed by detrusor pressure at maximal uroflow (72.6% and 70.5%), bladder contractility index, and postvoid residual from uroflowmetry (71.0% and 70.5%, respectively). CONCLUSIONS: Patients with MSA showed lower maximal flow rate, larger postvoid residual with decreased compliance, and impaired contractility, whereas patients with PD had higher incidence of detrusor overactivity and associated leakage. For differential diagnosis, postvoid residual from a pressure-flow study provided the best sensitivity and specificity. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that urodynamic measures can distinguish patients with MSA from those with PD.
引用
- Shin JH, Park KW, Heo KO, et al. Urodynamic study for distinguishing multiple system atrophy from Parkinson disease. Neurology. 2019. PMID: 31371567. doi:10.1212/WNL.0000000000008053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。